We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Technopath Clinical Diagnostics - An LGC Company

THERMO FISHER SCIENTIFIC

  Gold Thermo Fisher Scientific provides analytical instruments, lab equipment, specialty diagnostics, reagents and integrat... read more Featured Products: More products

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Accurate Genetic Assay Identifies Human Neutrophil Antigen 2 Deficiency

By LabMedica International staff writers
Posted on 08 Nov 2022
Print article
Image: The Applied Biosystems 96 well Veriti Thermal Cycler (Photo courtesy of Fisher Scientific)
Image: The Applied Biosystems 96 well Veriti Thermal Cycler (Photo courtesy of Fisher Scientific)

Human Neutrophil Antigen 2 (HNA-2) is one of the most important neutrophil antigens implicated in a number of human disorders. HNA-2 deficiency or HNA-2 null is a common phenotype observed in 3%–5% of US citizens.

HNA-2 null individuals are at risk to produce isoantibodies (or alloantibodies) that play important roles in transfusion-related acute lung injury, immune neutropenia, and bone marrow graft failure. CD177 coding SNP 787A > T (c.787A > T) is the most important genetic determinant for HNA-2 deficiency that involves human myeloproliferative disorders.

Biomedical Scientists at the University of Minnesota (St. Paul, MN, USA) recruited healthy blood donors at the Memorial Blood Center in St. Paul, MN, USA). The age of healthy control donors ranged from 19 to 84 years old. Human genomic DNA was isolated from EDTA anti-coagulated peripheral blood using the Wizard Genomic DNA Purification kit (Promega, Madison, WI, USA).

The expression of HNA-2 and the percentage of HNA-2+ neutrophils in healthy blood donors were determined. Fresh whole blood samples were stained with FITC-conjugated mouse anti-human CD177 (HNA-2) mAb MEM-166 or FITC-conjugated mIgG1 isotype control and analyzed on a FACS Canto flow cytometer (BD Biosciences, San Jose, CA, USA). A novel polymerase chain reaction (PCR) strategy was used to determine genotypes of the CD177 SNP c.787A > T.

In the simplified PCR assay, all allele specific primers and internal control primers were included in the same reaction, which ensures reliability of the assay. In addition, a novel high-throughput nested TaqMan assay was developed to determine genotypes of c.787A > T for large population genetic analysis of HNA-2 deficiency. The Applied Biosystems Veriti 96-well Thermal Cycler was used for the PCR reactions (Thermo Fisher Scientific, Waltham, MA, USA).

The scientists reported that CD177 SNP c787A > T genotypes of 396 subjects were 100% concordant among the single PCR reaction method, the nested TaqMan assay, and Sanger Sequencing analysis. Out of 396 subjects, all 18 donors with the CD177 STP homozygous genotype were HNA-2 null.

The authors concluded that the novel PCR-based genotyping assay is accurate to identify HNA-2 deficient individuals and is suitable for clinical laboratories. In addition, the innovative high-throughput nested TaqMan assay will be useful for large-scale population screens and genetic studies of HNA-2 deficiency. The study was on October 29, 2022 in the journal Transfusion Medicine.

Related Links:
University of Minnesota
Memorial Blood Center
Promega 
BD Biosciences 
Thermo Fisher Scientific 

Gold Supplier
Renin Control
Lumipulse Renin Control
New
Silver Supplier
Urinalysis Dipstick Control
Dipper Urinalysis Dipstick Control
New
Urine Analyzer
H-500
New
Blood Transfusion Safety Test
ABTest Card

Print article
SUGENTECH INC.

Channels

Clinical Chem.

view channel
Image: ELISA kit for liver-type fatty acid–binding protein (L-FABP). The level of L-FABP present in urine reflects the level of renal tubular dysfunction (Photo courtesy of Sekisui Medical Co)

Urinary Biomarkers Predict Weaning From Acute Dialysis Therapy

Acute kidney injury is associated with a higher risk of chronic kidney disease (CKD), end-stage renal disease, and long-term adverse cardiovascular effects. Critically ill patients with acute kidney injury... Read more

Microbiology

view channel
Image: Ring-form trophozoites of Plasmodium vivax in a thin blood smear (Photo courtesy of Centers for Disease Control and Prevention)

Immune Regulators Predict Severity of Plasmodium vivax Malaria

Cytokines and chemokines are immune response molecules that display diverse functions, such as inflammation and immune regulation. In Plasmodium vivax infections, the uncontrolled production of these molecules... Read more

Pathology

view channel
Image: Breast cancer spread uncovered by new molecular microscopy (Photo courtesy of Wellcome Sanger Institute)

New Molecular Microscopy Tool Uncovers Breast Cancer Spread

Breast cancer commonly starts when cells start to grow uncontrollably, often due to mutations in the cells. Overtime the tumor becomes a patchwork of cells, called cancer clones, each with different mutations.... Read more

Industry

view channel
Image: With Cell IDx’s acquisition, Leica Biosystems will be moving its multiplexing menu forward (Photo courtesy of Leica Biosystems)

Leica Biosystems Acquires Cell IDx, Expanding Offerings in Multiplexed Tissue Profiling

Leica Biosystems, a technology leader in automated staining and brightfield and fluorescent imaging (Nussloch, Germany), has acquired Cell IDx, Inc. (San Diego, CA, USA), which provides multiplex staining... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.